← All organizations

Highest phase reached
Phase 3
First clinical trial
Jul 1, 2014First marketed drug
Jun 1, 2005First NDA
Apr 29, 2016Last known activity
Nov 1, 2023
Timeline
Drugs by trial phase (4 distinct, 2 trials)
Phase 3 (4 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (27)
Recent trials (2)
- NCT03425799Lead sponsorPhase 3Sep 30, 2018
- NCT02216071Lead sponsorPhase 3Jul 1, 2014
Details
- Founded
- Lenoir, NC, US Jun 1, 2005
- First NDA
- Apr 29, 2016
- Last known activity
- Nov 1, 2023